Form 8-K Intra-Cellular Therapies For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Intra-cellular Therapies, Inc. (ITCI) Tops Q2 EPS by 8c
August 12, 2014 7:46 AM EDTIntra-cellular Therapies, Inc. (NASDAQ: ITCI) reported Q2 EPS of ($0.15), $0.08 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $319.2 thousand versus the consensus estimate of $410 thousand.
For earnings history and earnings-related data on Intra-cellular Therapies, Inc. (ITCI) click here.
... More